Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29044559 | 0.98 | TSHR (0.47) | TSHRLMNAALDH1A1KAT2BSMN1; SMN2 | |
| SCHEMBL19463301 | 0.98 | TSHR (0.47) | TSHRLMNAALDH1A1KAT2BSMN1; SMN2 | |
| SCHEMBL905407 | 0.98 | TSHR (0.47) | TSHRLMNAALDH1A1KAT2BSMN1; SMN2 | |
| SCHEMBL14141438 | 0.96 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BSMN1; SMN2 | |
| SCHEMBL2454952 | 0.93 | TSHR (0.50) | TSHRLMNAALDH1A1KAT2BSMN1; SMN2 | |
| SCHEMBL290461 | 0.91 | SMN1; SMN2 (0.40) | LMNAALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL905722 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2HPGDHTTKMT2A | |
| SCHEMBL905404 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2HPGDHTTKMT2A | |
| SCHEMBL4960230 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2HPGDHTTKMT2A | |
| SCHEMBL379163 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2HPGDHTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3171171-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2018-07-18 | — | — | EP | claimed |
| US-20170307633-A1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO-RAD LABORATORIES, INC | 2017-10-26 | — | — | US | claimed |
| US-20170146531-A1 | Recombinant Deamidated Gliadin Antigen | BIO-RAD LABORATORIES, INC. | 2017-05-25 | — | — | US | claimed |
| EP-3171171-A1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | Bio-rad Laboratories, Inc. (US) | 2017-05-24 | — | — | EP | claimed |
| EP-2788760-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES INC (US) | 2017-02-15 | — | — | EP | claimed |
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| EP-2659901-B1 | Recombinant deamidated gliadin antigen | BIO RAD LABORATORIES (US) | 2015-01-21 | — | — | EP | claimed |
| EP-2444807-B1 | MONO- AND DINITROPYRAZOLE HAPTEN CONJUGATES | VENTANA MED SYST INC (US) | 2014-06-11 | — | — | EP | claimed |
| EP-2659901-A1 | Recombinant deamidated gliadin antigen | Bio-Rad Laboratories, Inc. (US) | 2013-11-06 | — | — | EP | claimed |
| US-20130288274-A1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO-RAD LABORATORIES, INC. | 2013-10-31 | — | — | US | claimed |
| US-20070254311-A1 | Covalent modification and conjugation of luciferase | CARDIOGENICS INC. (CA) | 2007-11-01 | — | — | US | claimed |
| WO-2007046865-A1 | BIOLOGICAL INDICATOR | STERIS, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| US-20060269983-A1 | Biological indicator | AMERICAN STERILIZER COMPANY | 2006-11-30 | — | — | US | claimed |
| US-20060100163-A1 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-05-11 | — | — | US | claimed |
| EP-1549350-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | Fresenius Kabi Deutschland GmbH (DE) | 2005-07-06 | — | — | EP | claimed |
| US-20050100905-A1 | Novel method for production of dna biochips and applications thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 2005-05-12 | — | — | US | claimed |
| EP-1474368-A2 | NOVEL METHOD FOR PRODUCTION OF DNA BIOCHIPS AND APPLICATIONS THEREOF | CNRS (FR) | 2004-11-10 | — | — | EP | claimed |
| WO-2004032971-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-04-22 | — | — | WO | claimed |
| WO-2003068712-A2 | NOVEL METHOD FOR PRODUCTION OF DNA BIOCHIPS AND APPLICATIONS THEREOF | CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) (FR) | 2003-08-21 | — | — | WO | claimed |
| WO-2002023185-A2 | DEVICES AND METHODS FOR DIRECT ELECTRONIC READOUT OF BIOMOLECULAR INTERACTIONS | ENGENEOS, INC. (US) | 2002-03-21 | — | — | WO | claimed |